What you need to know about BioNTech — the European company behind Pfizer’s Covid-19 vaccine

December 22, 2021 RepMan Reputation Research Center

Before 2020, Germany’s BioNTech was a relatively little-known biotechnology company. That all changed when Covid-19 arrived.
On Monday, U.S. drug maker Pfizer announced an early analysis of its coronavirus vaccine — developed in partnership with BioNTech — was more than 90% effective in preventing Covid-19 among those without evidence of prior infection.
The news was hailed as a significant milestone in the race to deliver a vaccine that can help bring an end to the coronavirus pandemic. White House coronavirus advisor Dr. Anthony Fauci had previously said a vaccine that is 50% or 60% effective would be acceptable.

There are still huge challenges ahead for the development of a safe and effective vaccine, but as hopes rise worldwide, CNBC takes a look at BioNTech’s history.

MORE; please visit

← Corporate Reputation After a Year of Covid-19
Big Pharma’s COVID-19 reputation boost may not last — here’s why →